Published in Women's Health Weekly, June 1st, 1998
Anticoagulation therapy, a combination of aspirin and heparin, is used routinely for women who have experienced several spontaneous abortions and have a specific auto-antibody profile. The therapy is being used more broadly to treat in vitro fertilization (IVF) patients although scientific evidence of its effectiveness is limited.
The CDC recently investigated the death of a pregnant woman who had undergone IVF and aspirin and heparin therapy. Although...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly